Viyash Scientific Announces Q1 Results and Approves Employee Stock Option Scheme 2026
Viyash Scientific Limited (formerly Sequent Scientific Limited) has announced its unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026. The company also approved the allotment of equity shares to employees under the Viyash Scientific Limited Employee Stock Option Scheme, 2026 (ESOP Scheme 2026), and detailed the incorporation of a new subsidiary in Vietnam.The Board Meeting held on August 11, 2026, reviewed the performance across various segments and confirmed significant capital restructuring activities aimed at strengthening its subsidiaries’ financial foundations.
Q1 Financial Performance Highlights (Ended June 30, 2026)
Viyash Scientific reported strong consolidated results for the quarter compared to previous periods. The company's performance was reviewed by Statutory Auditors and presented alongside a Limited Review Report.Key figures from the unaudited financial statements are summarized below:
| Metric | Consolidated Results (3 months ended June 30, 2026) | Standalone Results (3 months ended June 30, 2026) |
|---|---|---|
| Revenue from operations | 9,463.60 | 3,536.90 |
| Total income | 9,546.70 | 3,682.80 |
| Profit after tax (PAT) | 792.90 | 209.20 |
Key Financial Takeaways:
- The consolidated total comprehensive income for the quarter stood at 729.50.
- In the standalone segment, the company recorded a profit after tax of 209.20.
Corporate Actions and Capital Restructuring
The Board meeting approved several corporate actions designed to optimize capital structure and expand global reach.Employee Stock Option Allotment:
Viyash Scientific Limited approved the allotment of 10,30,775 Equity Shares of Rs. 2 each to eligible optionees under the ESOP Scheme 2026. This action increased the issued and paid-up equity share capital from Rs. 87,77,53,626 to Rs. 87,98,15,176, comprising 43,99,07,588 Equity Shares of Rs. 2 each.
Global Expansion through Vietnam:
The company also approved the incorporation of a step-down subsidiary in Vietnam. This new entity will be established through Alivira Animal Health Limited (AAHL) or its step-down subsidiary, AAHL Ireland. The investment into the Vietnamese operation is set at up to USD 400,000.
Subscription for Wholly Owned Subsidiary
The Board approved the subscription of equity shares in Alivira Animal Health Limited (AAHL), a wholly owned subsidiary, through a Rights Issue.The total consideration for the proposed Rights Issue amounts to up to Rs. 400,02,15,648 (Rupees Four Hundred Crore Two Lakh Fifteen Thousand Six Hundred and Forty-Eight Only). This subscription amount is intended to be adjusted against intercompany loans previously extended by Viyash Scientific Limited, aiming to strengthen AAHL's capital structure and reduce interest burden.
Details of the acquired entity, AAHL, show that it was incorporated in India on September 30, 2013, and generates revenue within the pharmaceutical sector. For the financial year ended March 31, 2026, AAHL reported a turnover of Rs. 4,494.53 Million.
VIYASH Stock Price Movement
As of 1:37 PM, Viyash Scientific Limited shares are shedding value in live trading, dropping 2.92% to trade at ₹265.65. The stock has seen a total traded volume of 2.19 million shares so far into the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.